10 out of 10
CMS builds this single score out of ten separate indicators drawn from claims. A provider earns a point for each indicator where it is not an outlier against national thresholds. This one scores at or near the top of the scale.
| Indicator | This provider | Read as |
|---|---|---|
| Visits near death | 93.3% | higher is better |
| Gaps in nursing visits | 50.2% | lower is better |
| Early live discharges | 2.6% | lower is better |
| Late live discharges | 38.9% | lower is better |
| Burdensome transitions, Type 1 | 2.6% | lower is better |
| Burdensome transitions, Type 2 | 1.1% | lower is better |
| Skilled nursing minutes on weekends | 6.9% | higher is better |
| Nurse care minutes per routine home care days | 15.10 min | higher is better |
| CHC/GIP provided | 0.1% | higher is better |
| Per-beneficiary spending | $15,794 | context, not a quality score |
Why live discharges matter. Hospice is for people expected to die within six months. A patient leaving hospice alive is sometimes the right outcome — they got better, or chose to resume curative treatment. But an unusually high rate can also indicate patients were enrolled who did not qualify, or were discharged when their care became expensive. CMS publishes early and late live-discharge rates for exactly this reason. Treat a high number as a question to ask, not a verdict.
★★★★☆ 4/5 family survey rating
| Survey question | Families answering "always" / top box | |
|---|---|---|
| Rated this hospice 9 or 10 out of 10 | 86.0% | |
| Would definitely recommend | 91.0% | |
| Family member treated with respect | 95.0% | |
| Got the emotional and spiritual support they wanted | 93.0% |
CAHPS Hospice Survey, completed by caregivers after the patient's death. Providers with too few responses are not scored.
| Practice | Patients receiving it | |
|---|---|---|
| Composite process measure (all seven care practices) | 96.8% | |
| Pain screening | 99.8% | |
| Pain assessment | 97.0% | |
| Shortness-of-breath screening | 99.9% | |
| Shortness-of-breath treatment | 99.2% | |
| Bowel regimen for patients on opioids | 98.2% | |
| Treatment preferences documented | 100.0% | |
| Beliefs and values addressed | 99.5% |
Share of patients for whom the provider documented each practice. These are process measures — they record whether something was done, not how well.
Average daily census: 192 patients.
| Owner | Role | Share | Associated since | CMS type flags |
|---|---|---|---|---|
| ABIMBOLA FAMUYIDE | CORPORATE DIRECTOR | — | 2/18/2022 | — |
| ADAM HORST | CORPORATE OFFICER | 0% | 4/19/2021 | — |
| AJANI DUNN | CORPORATE OFFICER | 0% | 2/18/2022 | — |
| AJANI DUNN | CORPORATE DIRECTOR | 0% | 2/17/2023 | — |
| AMY WILLIAMS | CORPORATE DIRECTOR | — | 8/9/2019 | — |
| ANNE SWEENEY | CORPORATE DIRECTOR | — | 2/19/2016 | — |
| CHARANJIT RIHAL | CORPORATE DIRECTOR | — | 1/1/2021 | — |
| CHARLES SMITH | CORPORATE OFFICER | 0% | 2/16/2024 | — |
| CHRISTINA ZORN | CORPORATE OFFICER | — | 2/20/2015 | — |
| DENNIS DAHLEN | CORPORATE OFFICER | — | 1/1/2018 | — |
| DONALD REMY | CORPORATE DIRECTOR | 0% | 5/12/2023 | — |
| DOUGLAS BAKER | CORPORATE DIRECTOR | 0% | 8/14/2020 | — |
| ERIC MOORE | CORPORATE DIRECTOR | 0% | 2/20/2026 | — |
| GEORGE BILICIC | CORPORATE DIRECTOR | — | 11/9/2018 | — |
| GIANRICO FARRUGIA | CORPORATE OFFICER | — | 1/1/2019 | — |
| GIANRICO FARRUGIA | CORPORATE DIRECTOR | — | 1/1/2015 | — |
| JAMES FRANCIS | CORPORATE DIRECTOR | — | 1/1/2010 | — |
| JAMES ROBO | CORPORATE DIRECTOR | 0% | 2/16/2024 | — |
| JAY ALIX | CORPORATE DIRECTOR | — | 11/9/2018 | — |
| JED DAVIS | CORPORATE DIRECTOR | 0% | 2/17/2023 | — |
| JOSEPH COLAIANO | CORPORATE OFFICER | 0% | 2/20/2026 | — |
| JULIE GERBERDING | CORPORATE DIRECTOR | 0% | 11/10/2022 | — |
| KASI MCKAY | W-2 MANAGING EMPLOYEE | 0% | 5/1/2025 | — |
| KATHERINE BAICKER | CORPORATE DIRECTOR | 0% | 2/21/2020 | — |
| KENT THIELEN | CORPORATE OFFICER | — | 1/1/2019 | — |
| KENT THIELEN | CORPORATE DIRECTOR | — | 1/1/2019 | — |
| KEVIN WHITFORD | W-2 MANAGING EMPLOYEE | — | 4/1/2024 | — |
| KRISTIN PECK | CORPORATE DIRECTOR | 0% | 8/11/2023 | — |
| MARTINE ROTHBLATT | CORPORATE DIRECTOR | 0% | 11/10/2022 | — |
| MATTHEW CALLSTROM | CORPORATE DIRECTOR | — | 2/18/2022 | — |
| MICHAEL SHANNON | CORPORATE DIRECTOR | 0% | 8/9/2024 | — |
| NANCY PERETSMAN | CORPORATE DIRECTOR | 0% | 5/10/2019 | — |
| NATALIE CAINE | CORPORATE DIRECTOR | 0% | 2/16/2024 | — |
| NNEKA COMFERE | CORPORATE DIRECTOR | 0% | 2/16/2024 | — |
| PAUL GORMAN | CORPORATE DIRECTOR | — | 1/1/2011 | — |
| PETER LEE | CORPORATE DIRECTOR | 0% | 5/9/2025 | — |
| RAFAEL FONSECA | CORPORATE DIRECTOR | — | 1/1/2021 | — |
| RICHARD DAVIS | CORPORATE DIRECTOR | — | 1/1/2017 | — |
| RICHARD GRAY | CORPORATE OFFICER | 0% | 5/10/2019 | — |
| RICHARD GRAY | CORPORATE DIRECTOR | 0% | 5/10/2019 | — |
| ROBIN ROBERTS | CORPORATE DIRECTOR | 0% | 2/21/2020 | — |
| ROSHANAK DIDEHBAN | CORPORATE DIRECTOR | 0% | 2/21/2020 | — |
| SALLY BROWN | CORPORATE OFFICER | 0% | 2/21/2025 | — |
| SARAH MCLAUGHLIN | CORPORATE DIRECTOR | 0% | 2/21/2020 | — |
| URSULA BURNS | CORPORATE DIRECTOR | — | 1/1/2017 | — |
Source: CMS Hospice All Owners file, linked to this provider through its Medicare enrollment record. Medicare's Care Compare does not present ownership in this form.
Everything on this page is reproduced from the CMS Provider Data Catalog (July 2026 release) and, where shown, the CMS ownership and Medicare enrollment files. Nothing here is a rating or opinion of ours. If you believe a figure is wrong, email data@carerecords.org with the CCN and we verify against the official file within 5 business days.
How to cite this page: CareRecords, "Mayo Clinic Hospice — hospice records, Rochester, MN." Compiled from the CMS Provider Data Catalog (July 2026 release), CCN 241519. https://carerecords.org/hospice/minnesota/mayo-clinic-hospice-rochester/